Immunocore Holdings PLC
NASDAQ:IMCR
Immunocore Holdings PLC
NASDAQ:IMCR
Price:
60.23 USD
1.29%
Market Closed
Updated:
May 5, 2024
Immunocore Holdings PLC
Cash from Financing Activities
|
Immunocore Holdings PLC
Cash from Financing Activities Peer Comparison
Comparables:
CNTA
EXAI
AUTL
BCYC
GNS
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Financing Activities
£34.3m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
221%
|
CAGR 10-Years
N/A
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Financing Activities
$21.1m
|
CAGR 3-Years
149%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Exscientia PLC
NASDAQ:EXAI
|
Cash from Financing Activities
-£3.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Financing Activities
-$883k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Financing Activities
$250m
|
CAGR 3-Years
22%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Cash from Financing Activities
-£20.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immunocore Holdings PLC's Cash from Financing Activities?
Cash from Financing Activities
34.3m
GBP
34.3m
GBP
Based on the financial report for Dec 31, 2023, Immunocore Holdings PLC's Cash from Financing Activities amounts to 34.3m GBP.
What is Immunocore Holdings PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
221%
221%
Over the last year, the Cash from Financing Activities growth was -70%. The average annual Cash from Financing Activities growth rates for Immunocore Holdings PLC have been -33% over the past three years , 221% over the past five years .
You don't have any saved screeners yet
